Skip to content

Bill Nye is back in his lab with NAF and Biogen—breaking down the science of Friedreich Ataxia in a new video series. WATCH NOW

Ataxia Treatment Pipeline

Tracking progress of the development of Ataxia therapies.

Treatment development is a long process that involves multiple phases of a clinical trial and oversight by the Food and Drug Administration (FDA). NAF is committed to empowering you with up-to-date information about Ataxia treatment development. The pipelines are visual tools that were created to show the progress of all Ataxia therapies that are currently being developed. There is a pipeline for each type of Ataxia that currently has therapies in development. 

Select a type of Ataxia to learn more: 

To learn more about participating in research visit our PrepRARE Clinical Trial Readiness Education page.

Print Friendly, PDF & Email
Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.